The Cooper Companies (COO) Traded Down in Q2 Despite Strong Results

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets made a significant rebound during the quarter, increasing 23% from intra-period lows to close at record highs. Against this backdrop, the fund returned 4.10% (net) compared to the Russell 2500 Growth Index’s 11.31% return. In addition, please check the fund’s top five holdings to know its best picks in 2025.

In its second-quarter 2025 investor letter, Meridian Growth Fund highlighted stocks such as The Cooper Companies, Inc. (NASDAQ:COO). The Cooper Companies, Inc. (NASDAQ:COO) manufactures and markets contact lenses that operate through CooperVision and CooperSurgical segments. The one-month return of The Cooper Companies, Inc. (NASDAQ:COO) was -1.83%, and its shares lost 22.95% of their value over the last 52 weeks. On August 11, 2025, The Cooper Companies, Inc. (NASDAQ:COO) stock closed at $70.88 per share, with a market capitalization of $14.141 billion.

Meridian Growth Fund stated the following regarding The Cooper Companies, Inc. (NASDAQ:COO) in its second quarter 2025 investor letter:

“The Cooper Companies, Inc. (NASDAQ:COO) is a medical technology firm with two main divisions: CooperVision, a leader in contact lenses, and CooperSurgical, which focuses on women’s health, including reproductive care and fertility. Despite strong quarterly performance and a full-year guidance raise, the stock fell on slightly lowered growth forecasts for the contact lens industry. While still growing faster than the industry, the lower guidance brought a punitive response from investors, a recurring theme for healthcare companies. We maintain confidence in the company’s fundamentals and long-term growth potential, and slightly trimmed our position in the company during the period.”

Why The Cooper Companies, Inc. (COO) Crashed Last Week

A doctor wearing gloves and a mask holding a pair of contact lenses in their hand.

The Cooper Companies, Inc. (NASDAQ:COO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 44 hedge fund portfolios held The Cooper Companies, Inc. (NASDAQ:COO) at the end of the first quarter, which was 52 in the previous quarter. The Cooper Companies, Inc. (NASDAQ: COO) reported revenue of $1.002 billion in fiscal second quarter of 2025, reflecting a 6% year-over-year increase, with 7% organic growth. While we acknowledge the risk and potential of The Cooper Companies, Inc. (NASDAQ:COO) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than The Cooper Companies, Inc. (NASDAQ:COO) and that has 10,000% upside potential, check out our report about this cheapest AI stock.

In another article, we covered The Cooper Companies, Inc. (NASDAQ:COO) and shared Baron Health Care Fund’s views on the company. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.